This Press Release updates numerical list in reference section Theralase® validates previous University of Manitoba research ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ACCES ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the ...
Lysine is an essential amino acid that plays a vital role in overall health. Since the body cannot produce it, lysine must be ...
The overall market of herpes simplex is expected to boost with the expected launch of emerging therapy, increased awareness, and extensive research in the forecast period (2025-2034). LAS ...
Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection.
Herpes Labialis Treatment Market. The global herpes labialis treatment market is on track for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 4.7% from ...
According to recent estimates from the World Health Organization, more than one in five people aged 15–49 live with genital herpes.
The possibility that Alzheimer’s disease diagnosis is associated with viruses, bacteria, fungi, and parasites has been postulated over the past three decades. (L-R) In green - herpes virus proteins.
Genital herpes is a sexually transmitted infection (STI) caused by the herpes simplex virus, which also causes cold sores. There are two types of herpes simplex virus, HSV-1 and HSV-2 (and it's ...